{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Event",
"name": "ASCO 2026 Annual Meeting",
"url": "https://www.fortrea.com/insights/events/asco-2026",
"description": "Join Fortrea at ASCO 2026 in Chicago, May 29–June 2, and connect with our clinical trial experts at booth 13141. As one of the most significant gatherings for oncology professionals, ASCO provides an opportunity to explore innovative approaches to cancer research and trial delivery. Meet our team to discuss your pipeline needs and discover how we support oncology development from early-phase studies through post-approval.",
"startDate": "2026-05-29",
"endDate": "2026-06-02",
"eventAttendanceMode": "https://schema.org/OfflineEventAttendanceMode",
"eventStatus": "https://schema.org/EventScheduled",
"location": {
"@type": "Place",
"name": "McCormick Place",
"address": {
"@type": "PostalAddress",
"addressLocality": "Chicago",
"addressRegion": "IL",
"addressCountry": "US"
}
},
"organizer": {
"@type": "Organization",
"name": "American Society of Clinical Oncology",
"url": "https://www.asco.org/"
},
"contributor": [
{
"@type": "Person",
"name": "Oren Cohen, MD",
"jobTitle": "Chief Medical Officer, Fortrea",
"url": "https://www.fortrea.com/about-us/our-experts/oren-cohen-md",
"worksFor": {
"@id": "https://www.fortrea.com/#organization"
}
},
{
"@type": "Person",
"name": "Laura Vidal, MD",
"jobTitle": "Vice President and Therapeutic Strategy Lead, Fortrea",
"url": "https://www.fortrea.com/about-us/our-experts/laura-vidal-md",
"worksFor": {
"@id": "https://www.fortrea.com/#organization"
}
},
{
"@type": "Person",
"name": "Kamal Veer Saini, MBBS, MD, MRCP (UK), DM",
"jobTitle": "Executive Medical Director, & Head of European Oncology Medical Team",
"url": "https://www.fortrea.com/about-us/our-experts/kamal-saini-md",
"worksFor": {
"@id": "https://www.fortrea.com/#organization"
}
}
]
},
{
"@type": "CollectionPage",
"url": "https://www.fortrea.com/insights/events/asco-2026",
"name": "Fortrea at ASCO 2026 Annual Meeting",
"description": "Join Fortrea at ASCO 2026 in Chicago, May 29–June 2, and connect with our clinical trial experts at booth 13141. As one of the most significant gatherings for oncology professionals, ASCO provides an opportunity to explore innovative approaches to cancer research and trial delivery. Meet our team to discuss your pipeline needs and discover how we support oncology development from early-phase studies through post-approval.",
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"mainEntity": [
{
"@id": "https://www.fortrea.com/insights/events/asco-2026#event"
},
{
"@type": "ItemList",
"name": "Fortrea Contributions at ASCO 2026",
"itemListElement": [
{
"@type": "CreativeWork",
"name": "ASCO 2026 Poster",
"headline": "Real-world effectiveness of MET inhibitors versus immunotherapy ± chemotherapy in 1L for patients with MET exon 14 skipping mutations in non-small cell lung cancer.",
"author": [
{ "@type": "Person", "name": "Kamal S. Saini" },
{ "@type": "Person", "name": "Maria Ignacia Berraondo" },
{ "@type": "Person", "name": "Paulo Ricardo Santos Nunes Filho" },
{ "@type": "Person", "name": "Carolina Dutra" },
{ "@type": "Person", "name": "Luca Cantini" }
],
"isPartOf": {
"@id": "https://www.fortrea.com/insights/events/asco-2026#event"
}
},
{
"@type": "CreativeWork",
"name": "ASCO 2026 Abstract",
"headline": "Treatment Strategies in Metastatic NSCLC after progression to Immuno-chemotherapy: A Random Effects Network Meta Analysis of Phase III Trials.",
"author": [
{ "@type": "Person", "name": "Luca Cantini" },
{ "@type": "Person", "name": "Kamal S. Saini" },
{ "@type": "Person", "name": "Maria Garcia Requesens" }
],
"isPartOf": {
"@id": "https://www.fortrea.com/insights/events/asco-2026#event"
}
}
]
}
],
"hasPart": {
"@type": "WebPage",
"name": "ASCO 2025 Annual Meeting Highlights",
"url": "https://www.fortrea.com/insights/events/asco-2025"
}
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Events",
"item": "https://www.fortrea.com/insights/events"
},
{
"@type": "ListItem",
"position": 4,
"name": "ASCO 2026 Annual Meeting",
"item": "https://www.fortrea.com/insights/events/asco-2026"
}
]
}
]
}